F. M. Comoglio, F. Osella, A. Pagano, E. Pilloni, I. Vanacore, M. Verra, C. Filippini, C. Desanctis, A. Revelli
{"title":"Efficacy of Oral Misoprostol Compared with Vaginal Dinoprostone for Cervical Ripening and Labor Induction","authors":"F. M. Comoglio, F. Osella, A. Pagano, E. Pilloni, I. Vanacore, M. Verra, C. Filippini, C. Desanctis, A. Revelli","doi":"10.29011/2577-2236.100185","DOIUrl":null,"url":null,"abstract":"Objective: The study focuses on the pharmacological induction of labor and aims at comparing oral misoprostol (Cytotec ® ) with vaginal dinoprostone (slow-release vaginal insert Propess ® and vaginal gel Prepidil ® ). Methods: A retrospective observational study was conducted. Through medical records review, we collected data on women at term with a singleton pregnancy who underwent labor induction at our tertiary care center, Sant’Anna Hospital of Turin, from January 2018 to January 2023. A total of 1230 were included: 446 received oral misoprostol","PeriodicalId":365505,"journal":{"name":"Obstetrics & Gynecology: Open Access","volume":" 5","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obstetrics & Gynecology: Open Access","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29011/2577-2236.100185","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: The study focuses on the pharmacological induction of labor and aims at comparing oral misoprostol (Cytotec ® ) with vaginal dinoprostone (slow-release vaginal insert Propess ® and vaginal gel Prepidil ® ). Methods: A retrospective observational study was conducted. Through medical records review, we collected data on women at term with a singleton pregnancy who underwent labor induction at our tertiary care center, Sant’Anna Hospital of Turin, from January 2018 to January 2023. A total of 1230 were included: 446 received oral misoprostol